Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:BBI

Brickell Biotech (BBI) Stock Price, News & Analysis

Brickell Biotech logo

About Brickell Biotech Stock (NASDAQ:BBI)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$0.77
$0.93
52-Week Range
N/A
Volume
31,300 shs
Average Volume
206,730 shs
Market Capitalization
$6.75 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive BBI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Brickell Biotech and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

BBI Stock News Headlines

Brickell hotel sold by royal family member for $55M
New Biotech Backed by Proven Incubator Now Open to Public
A successful biotech incubator just opened its next chapter - and you're invited to their raise. This deal comes from the same team that helped guide ANOTHER rare disease biotech to a $680M acquisition. Now, they've lined up a new candidate: a drug with orphan status and fast-track designation, entering Phase 2 trials.tc pixel
Seattle Biotech News
Nuclear Receptor ROR-Gamma Market Size by 2030
Brickell City Centre
Biotech News
See More Headlines

BBI Stock Analysis - Frequently Asked Questions

Brickell Biotech, Inc. (NASDAQ:BBI) issued its quarterly earnings data on Thursday, August, 11th. The company reported ($0.01) earnings per share for the quarter, topping the consensus estimate of ($1.48) by $1.47. Brickell Biotech had a negative trailing twelve-month return on equity of 156.10% and a negative net margin of 643.48%.

Brickell Biotech shares reverse split on the morning of Tuesday, July 5th 2022.The 1-45 reverse split was announced on Tuesday, July 5th 2022. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, July 5th 2022. An investor that had 100 shares of stock prior to the reverse split would have 2 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some other companies that Brickell Biotech investors own include Tonix Pharmaceuticals (TNXP), TherapeuticsMD (TXMD), Alphabet (GOOG), NVIDIA (NVDA), Ocugen (OCGN), Meta Platforms (META) and Tesla (TSLA).

Company Calendar

Last Earnings
8/11/2022
Today
9/16/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biological Products, Except Diagnostic
Sub-Industry
N/A
Current Symbol
NASDAQ:BBI
CIK
819050
Employees
16
Year Founded
2009

Profitability

EPS (Trailing Twelve Months)
($13.52)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$39.47 million
Net Margins
-643.48%
Pretax Margin
-643.48%
Return on Equity
-156.10%
Return on Assets
-128.23%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
6.36
Quick Ratio
6.36

Sales & Book Value

Annual Sales
$4.64 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$9.75 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
2,874,000
Free Float
2,744,000
Market Cap
$6.75 million
Optionable
Not Optionable
Beta
0.02

Social Links

(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report

This page (NASDAQ:BBI) was last updated on 9/16/2025 by MarketBeat.com Staff
From Our Partners